Aptamers, like antibodies, can specifically bind to targets and modulate or block their activity. An in vitro selection process from pools of random sequence oligonucleotides has generated aptamers for over 100 proteins including growth factors, transcription factors, enzymes, and immunoglobulins.
With years of ample experience in antibody drug development, our scientists are confident in providing a full range of aptamer development services to promote the development of complement therapeutics. Creative Biolabs is proud to offer aptamer development services in a timely and cost-effective manner. We offer turn-key or ala carte services customized to our client’s needs.
Author Profile
Latest entries
Tech15/09/2023Lipid nanoparticle development
Tech15/09/2023Functional Liposome Development
Tech15/09/2023Liposomal Formulation
Tech15/09/2023Liposome Development
